February 2017 update

To our A Fair Shot supporters wondering how the progress is going with GSK and Pfizer, we have an update for you! In September and November 2016, GSK and Pfizer (respectively) made commitments to offer humanitarian organisations working in emergencies the lowest global price for the pneumonia vaccine. More than 3 months have passed since the companies made their announcements. As of late February 2017, negotiations with both companies are just beginning. We hope that Pfizer and GSK will deliver on their promises and make the pneumonia vaccine available to children living in emergency contexts as soon as possible.

""
Vax_CAR_Measles_MagaliDeppen_2015_MSF152051 Photograph by Magali Deppen

A Fair Shot

Thank you for helping us raise the pressure and  #AskPharma to lower the price of the pneumonia vaccine! Over 416,272 peoplefrom 170 countries signed our petition, which was handed to Pfizer and GSK in New York, London, and Madrid.

On April 27, 2016, we carried your voices to Pfizer Headquarters, and they accepted our petition. Thanks to your actions agreements are now in place with Pfizer and GSK for humanitarian organizations like MSF to obtain lowest global price for PCV, around US$9 per child (for all three doses).

This campaign is not over, we are still asking Pfizer and GSK to lower the prices of the vaccine to $5 per child for all developing countries.

Photograph by Magali Deppen

Give All Children A Fair Shot

Join us in demanding a lower price
for pneumonia vaccine, and help save nearly
1 million children every year!